Lihong Zhang
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Empagliflozin attenuates renal tubular ferroptosis in preeclampsia via tazarotene-induced gene 1.
Journal: European journal of pharmacology
Published: November 13, 2023
Association between hearing loss and physical performance in patients on maintenance hemodialysis.
Journal: Kidney research and clinical practice
Published: October 11, 2022
Decreased Ang-(1-7) and Downregulated Intrarenal RAS May Contribute to the Direct Podocyte Injury With Proteinuria in Preeclampsia.
Journal: Reproductive sciences (Thousand Oaks, Calif.)
Published: January 01, 2019
Angiotensin II Type I Receptor Agonistic Autoantibody Induces Podocyte Injury via Activation of the TRPC6- Calcium/Calcineurin Pathway in Pre-Eclampsia.
Journal: Kidney & blood pressure research
Published: April 13, 2018
The BET bromodomain inhibitor exerts the most potent synergistic anticancer effects with quinone-containing compounds and anti-microtubule drugs.
Journal: Oncotarget
Published: June 06, 2016
Effective prediction of preeclampsia by measuring serum angiotensin II, urinary angiotensinogen and urinary transforming growth factor β1.
Journal: Experimental and therapeutic medicine
Published: September 05, 2015
Angiotensin-(1-7) attenuates damage to podocytes induced by preeclamptic serum through MAPK pathways.
Journal: International journal of molecular medicine
Published: April 06, 2014
Effects of angiogenic factors, antagonists, and podocyte injury on development of proteinuria in preeclampsia.
Journal: Reproductive sciences (Thousand Oaks, Calif.)
Published: September 20, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026